How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

43,415 results for

Metabolic Syndrome

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Relationship between legumes consumption and metabolic syndrome: a meta-analysis of observational studies

Relationship between legumes consumption and metabolic syndrome: a meta-analysis of observational studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

102. The risk of acute kidney injury in adult surgical patients with metabolic syndrome: a systematic review and meta-analysis

The risk of acute kidney injury in adult surgical patients with metabolic syndrome: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

103. Glycemic index, glycemic load and risk of metabolic syndrome: a systematic review and dose-response meta-analysis of observational studies

Glycemic index, glycemic load and risk of metabolic syndrome: a systematic review and dose-response meta-analysis of observational studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

104. Carbohydrates intake and risk of metabolic syndrome: a meta-analysis of healthy people

Carbohydrates intake and risk of metabolic syndrome: a meta-analysis of healthy people Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

105. Breast cancer risk associated with glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes, prediabetes, obesity and metabolic syndrome: a systematic review

Breast cancer risk associated with glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes, prediabetes, obesity and metabolic syndrome: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

106. Effect of whey protein on metabolic syndrome components: a systematic review and meta analysis

Effect of whey protein on metabolic syndrome components: a systematic review and meta analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

107. Effects of vitamin D supplementation on fasting glucose, lipid profile, blood pressure, and abdominal obesity among patients with metabolic syndrome: a systematic review and meta-analysis of clinical trials

Effects of vitamin D supplementation on fasting glucose, lipid profile, blood pressure, and abdominal obesity among patients with metabolic syndrome: a systematic review and meta-analysis of clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

108. Effectiveness of mobile health technologies assisting physical activity (PA) and lifestyle interventions to reduce cardiovascular risk indicators in metabolic syndrome patients: a systematic review and meta-analysis

Effectiveness of mobile health technologies assisting physical activity (PA) and lifestyle interventions to reduce cardiovascular risk indicators in metabolic syndrome patients: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete

2019 PROSPERO

109. Prevalence of metabolic syndrome in adult sub-Sahara African community: systematic review and meta analysis

Prevalence of metabolic syndrome in adult sub-Sahara African community: systematic review and meta analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

110. Fetuin-A and Fetuin-B in Metabolic syndrome and: a systematic review and meta-analysis

Fetuin-A and Fetuin-B in Metabolic syndrome and: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

111. Association between fat free mass/lean body mass and metabolic syndrome in children: systematic review

Association between fat free mass/lean body mass and metabolic syndrome in children: systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

112. Effect of omega-3 fatty acid supplementation on components of metabolic syndrome in patients with Human Immunodeficiency Virus infection (HIV) in High Activity Antiretroviral Therapy (HAART): a systematic review and meta-analysis of randomized controlled

Effect of omega-3 fatty acid supplementation on components of metabolic syndrome in patients with Human Immunodeficiency Virus infection (HIV) in High Activity Antiretroviral Therapy (HAART): a systematic review and meta-analysis of randomized controlled Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied

2019 PROSPERO

113. Impact of fecal microbiota transplantation on obesity with metabolic syndrome - a systematic review and meta-analysis

Impact of fecal microbiota transplantation on obesity with metabolic syndrome - a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

114. Does a gluten-free diet improve metabolic syndrome? A systematic review

Does a gluten-free diet improve metabolic syndrome? A systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

115. A systematic review and meta-analysis of randomized controlled trials of mobile health interventions for patients with metabolic syndrome

A systematic review and meta-analysis of randomized controlled trials of mobile health interventions for patients with metabolic syndrome Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

116. Do dietary choices alone alter the risk of developing metabolic syndrome?

Do dietary choices alone alter the risk of developing metabolic syndrome? Do dietary choices alone alter the risk of developing metabolic syndrome? Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Do dietary choices alone alter the risk of developing metabolic syndrome? View/ Open Date 2013-09 Format Metadata Abstract (...) In studies of patient populations controlled for differences in dietary content alone, independent of weight loss or exercise changes, diets with high glycemic index foods, low whole grain and fiber content, and low fruit and vegetable content are associated with an increased incidence of metabolic syndrome (strength of recommendation [SOR]: B, multiple large cohort studies). In the short term, however, switching patients at high risk for metabolic syndrome from a high- to low-glycemic index diet doesn't

2014 Clinical Inquiries

117. Evaluation of the Japanese Metabolic Syndrome Risk Score (JAMRISC): a newly developed questionnaire used as a screening tool for diagnosing metabolic syndrome and insulin resistance in Japan (PubMed)

Evaluation of the Japanese Metabolic Syndrome Risk Score (JAMRISC): a newly developed questionnaire used as a screening tool for diagnosing metabolic syndrome and insulin resistance in Japan To prevent the onset of lifestyle-related diseases associated with metabolic syndrome (MetS) in Japan, research into the development of a useful screening method is strongly desired. We developed a new screening questionnaire (JAMRISC) utilizing a logistic regression model and evaluated its ability (...) to predict the development of MetS, type 2 diabetes and other lifestyle-related diseases in Japanese populace.JAMRISC questionnaire was sent to 1,850 individuals in Rumoi, a small city in Hokkaido. We received a total of 1,054 valid responses. To maximize the target individuals accurately diagnosed with MetS, logistic regression analysis was used to generate a unique metabolic syndrome score calculation formula as taking into consideration the clinical relevance of each question item as individual

Full Text available with Trip Pro

2016 Environmental health and preventive medicine

118. Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: A randomized trial. Effects of probiotics on metabolic syndrome. (PubMed)

Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: A randomized trial. Effects of probiotics on metabolic syndrome. Human studies have shown the beneficial effects of probiotic microorganisms on the parameters of metabolic syndrome (MetS) and other cardiovascular risks, but to our knowledge the effect of Bifidobacterium lactis has not yet been reported. The aim of this study was to evaluate the effect of consumption of milk (...) containing the probiotic B. lactis HN019 on the classical parameters of MetS and other related cardiovascular risk factors.Fifty-one patients with MetS were selected and divided into a control group (n = 25) and a probiotic group (n = 26). The probiotic group consumed fermented milk with probiotics over the course of 45 d. The effects of B. lactis on lipid profile, glucose metabolism, and proinflammatory cytokines (tumor necrosis factor-α and interleukin-6) were assessed in blood samples

2016 Nutrition (Burbank, Los Angeles County, Calif.)

119. Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA₂ in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome. (PubMed)

Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA₂ in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome. Apolipoprotein (Apo) B-48 is an intestinally derived lipoprotein that is expected to be a marker for cardiovascular disease (CVD). Lipoprotein-associated phospholipase A₂ (Lp-PLA₂) is a vascular-specific inflammatory marker and important risk predictor of CVD (...) . The aim of this study was to explore the effect of pitavastatin treatment and life style modification (LSM) on ApoB-48 and Lp-PLA₂ levels in metabolic syndrome (MS) patients at relatively low risk for CVD, as a sub-analysis of a previous multi-center prospective study.We enrolled 75 patients with MS from the PROPIT study and randomized them into two treatment groups: 2 mg pitavastatin daily+intensive LSM or intensive LSM only. We measured the change of lipid profiles, ApoB-48 and Lp-PLA₂ for 48

Full Text available with Trip Pro

2016 Endocrinology and metabolism (Seoul, Korea)

120. Erratum to: Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome (PubMed)

Erratum to: Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome 27013318 2016 07 04 2018 11 13 1471-2318 16 2016 Mar 24 BMC geriatrics BMC Geriatr Erratum to: Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome. 71 10.1186/s12877-016-0241-2 Lee Sangjin S Office for Planning and Coordination, Division of Planning and Coordination, Ministry of Health & Welfare, 13, Doum

Full Text available with Trip Pro

2016 BMC geriatrics

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>